Curtis Ruegg

2.0k total citations · 1 hit paper
29 papers, 1.7k citations indexed

About

Curtis Ruegg is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Curtis Ruegg has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Curtis Ruegg's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Curtis Ruegg is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Curtis Ruegg collaborates with scholars based in United States and France. Curtis Ruegg's co-authors include Mette Strand, S. K. Patel, Henry Lamparski, Jean‐Bernard Le Pecq, Di‐Hwei Hsu, Edgar G. Engleman, Craig Monell, Reiner Laus, Dirk G. Brockstedt and Lawrence Fong and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Curtis Ruegg

29 papers receiving 1.6k citations

Hit Papers

Production and characterization of clinical grade exosome... 2002 2026 2010 2018 2002 200 400 600

Peers

Curtis Ruegg
Elizabeth Montabana United States
Ann Cheung United States
Charles A. Nicolette United States
Theodore E. Maione United States
J J Toole United States
Elizabeth Montabana United States
Curtis Ruegg
Citations per year, relative to Curtis Ruegg Curtis Ruegg (= 1×) peers Elizabeth Montabana

Countries citing papers authored by Curtis Ruegg

Since Specialization
Citations

This map shows the geographic impact of Curtis Ruegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis Ruegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis Ruegg more than expected).

Fields of papers citing papers by Curtis Ruegg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtis Ruegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis Ruegg. The network helps show where Curtis Ruegg may publish in the future.

Co-authorship network of co-authors of Curtis Ruegg

This figure shows the co-authorship network connecting the top 25 collaborators of Curtis Ruegg. A scholar is included among the top collaborators of Curtis Ruegg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curtis Ruegg. Curtis Ruegg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarde, Aurélien, et al.. (2020). Selectivity of T Cell Engager AMV564 Against Different Leukemic Blast Populations and Potential Application for Patient Selection. Blood. 136(Supplement 1). 25–26. 3 indexed citations
2.
Piha‐Paul, Sarina A., Alexander Starodub, Michael Shafique, et al.. (2020). 372 Single-agent anti-tumor activity in relapsed/refractory solid tumors: interim data from the phase 1 solid tumor trial of AMV564, a novel T-cell engager. SHILAP Revista de lepidopterología. A226.2–A227. 2 indexed citations
3.
Gregory, Richard W., et al.. (2013). A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype A. Journal of Pharmacological and Toxicological Methods. 69(2). 103–107. 3 indexed citations
4.
Ruegg, Curtis, et al.. (2011). Characterization of diffusion and duration of action of a new botulinum toxin type A formulation. Toxicon. 58(2). 159–167. 34 indexed citations
5.
Lamparski, Henry, et al.. (2002). Production and characterization of clinical grade exosomes derived from dendritic cells. Journal of Immunological Methods. 270(2). 211–226. 600 indexed citations breakdown →
6.
Fong, Lawrence, Dirk G. Brockstedt, Claudia Benike, et al.. (2001). Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy. The Journal of Immunology. 167(12). 7150–7156. 202 indexed citations
7.
André, Fabrice, Michael Brun Andersen, Joseph Wolfers, et al.. (2001). Exosomes in cancer immunotherapy: preclinical data. Advances in experimental medicine and biology. 495. 349–354. 30 indexed citations
8.
Peshwa, Madhusudan V., Jia Shi, Curtis Ruegg, Reiner Laus, & Wim C. A. van Schooten. (1998). Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide. The Prostate. 36(2). 129–138. 102 indexed citations
9.
Fong, Lawrence, Curtis Ruegg, Dirk G. Brockstedt, E G Engleman, & Reiner Laus. (1997). Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer. The Journal of Immunology. 159(7). 3113–3117. 108 indexed citations
11.
Ruegg, Curtis, et al.. (1996). B4B, a novel growth-arrest gene, is expressed by a subset of progenitor/pre-B lymphocytes negative for cytoplasmic mu-chain. The Journal of Immunology. 157(1). 72–80. 24 indexed citations
12.
Ruegg, Curtis, et al.. (1995). V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene.. The Journal of Immunology. 154(9). 4434–4443. 24 indexed citations
13.
Rivas, A, Curtis Ruegg, Reiner Laus, et al.. (1995). V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.. The Journal of Immunology. 154(9). 4423–4433. 26 indexed citations
15.
Auvinet, Edouard, et al.. (1991). The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.. PubMed. 8(5). 351–8. 4 indexed citations
17.
Ruegg, Curtis & Edgar G. Engleman. (1990). Impaired Immunity in AIDS. Annals of the New York Academy of Sciences. 616(1). 307–317. 16 indexed citations
18.
Lawton, Michael, et al.. (1990). Hepatic bilirubin and UDP-glucuronate levels in bolivian squirrel monkeys exhibiting fasting hyperbilirubinemia. International Journal of Biochemistry. 22(1). 61–65. 6 indexed citations
19.
Ruegg, Curtis, et al.. (1990). Preparation of proteosome-based vaccines correlation of immunogenicity with physical characteristics. Journal of Immunological Methods. 135(1-2). 101–109. 8 indexed citations
20.
Ruegg, Curtis, Craig Monell, & Mette Strand. (1989). Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. Journal of Virology. 63(8). 3257–3260. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026